Israeli ophthalmologists, Dr. David Smadja, has invented and patented eye drops which repair the corneas while improving near-sighted and far-sighted vision.
The synthetic nanoparticle solution can replace multifocal lenses so that people could see an object from various distances.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
This new concept for correcting refractory problems could revolutionize both ophthalmological and optometry treatment of patients with hyperopia (farsightedness), myopia (nearsightedness), and more refractory conditions, The Jerusalem Post reported.
‘Nanodrops’ were successfully tested on pigs. Later this year they are expected to be tested on humans in clinical trials, according to a research made in collaboration of Shaare Zedek Medical Center and Bar-Ilan University’s Institute of Nanotechnology and Advanced Materials (BINA).
If the ‘nanodrops’ show improvement in humans the solution could eliminate the need for eyeglasses, Dr. David Smadja said at Shaare Zedek’s second annual research conference in February.
According to Jerusalem Post the measurement of the eye refraction would be available via an application on the smartphone. this first step would provide data on how much adjustment needs to be done. This has already been done successfully on pig eyes.
Then a laser would create a pattern and “stamped” on the corneal surface of the eyes by a surgical procedure. The nanodrops will later be put in for the completion of the treatment